EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
44 hedge funds and large institutions have $8.59M invested in Evofem Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 34 closing their positions.
Holders
44
Holders Change
-24
Holders Change %
-35.29%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
16
Reduced
13
Closed
34
Calls
$3.83M
Puts
$1.18M
Net Calls
+$2.65M
Net Calls Change
+$2.08M
Top Buyers
1 |
BBA
1
Baker Bros. Advisors
New York
|
$2.92M |
2 |
![]()
2
Alyeska Investment Group
Chicago,
Illinois
|
$2.2M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$1.47M |
4 |
4
Citigroup
New York
|
$832K |
5 |
5
Citadel Advisors
Miami,
Florida
|
$238K |